Publications by authors named "Daniel Cochrane"

Claim this Profile
V
Virion proteomics of genetically intact HCMV reveals a regulator of envelope glycoprotein composition that protects against humoral immunity.
Kirsten Bentley, Evelina Statkute, Isa Murrell, Ceri A Fielding, Robin Antrobus, Daniel Cochrane

Proc Natl Acad Sci U S A· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RESNA position paper on the capacity-building role of assistive technology specialists in PreK-12 educational settings.
Alicia M Drelick, Daniel P Cochrane, Linda Potts

Assist Technol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance of the T-SPOT.COVID test for detecting SARS-CoV-2-responsive T cells.
Margaret Kruse, Chris Dark, Megan Aspden, Daniel Cochrane, Rick Competiello

Int J Infect Dis· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polyvalent Diazonium Polymers Provide Efficient Protection of Oncolytic Adenovirus Enadenotucirev from Neutralizing Antibodies while Maintaining Biological Activity In Vitro and In Vivo.
Nora Francini, Daniel Cochrane, Sam Illingworth, Laura Purdie, Giuseppe Mantovani

Bioconjug Chem· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human cytomegalovirus UL141 promotes efficient downregulation of the natural killer cell activating ligand CD112.
Virginie Prod'homme, Daniel M Sugrue, Richard J Stanton, Akio Nomoto, James Davies, Daniel Cochrane

J Gen Virol· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modulation of natural killer cells by human cytomegalovirus.
Gavin W G Wilkinson, Peter Tomasec, Richard J Stanton, Melanie Armstrong, Virginie Prod'homme, Daniel Cochrane

J Clin Virol· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Macrophages in chronic type 2 inflammation have a novel phenotype characterized by the abundant expression of Ym1 and Fizz1 that can be partly replicated in vitro.
Meera G Nair, Daniel W Cochrane, Judith E Allen

Immunol Lett· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis